Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
1.
Lett Appl Microbiol ; 68(6): 537-545, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30933376

RESUMEN

Viable but nonculturable (VBNC) Vibrio parahaemolyticus cannot be detected by the standard cultivation-based methods. In this study, commonly used viability assessment methods were evaluated for the detection of V. parahaemolyticus in a VBNC state. Vibrio parahaemolyticus cells exposed to nutrient deficiency at cold temperature were used for epifluorescence microscopy with SYTO9 and propidium iodide (PI) staining and real-time polymerase chain reaction (qPCR) with propidium monoazide (PMA), and its resuscitative ability was determined by a temperature upshift in freshly prepared artificial sea water (ASW; pH 7) fluids. Viable cells with intact membranes always exceeded 5·0 log CFU per ml in ASW microcosms at 4°C. After 80 days, cycle thresholds for V. parahaemolyticus ATCC 27969 were 16·15-16·69. During cold-starvation, PMA qPCR selectively excluded DNAs from heat-killed cells. However, there may be some penetration of PMA into undamaged cells that persisted in ASW for 150 days, as evidenced by their ability to resuscitate from a VBNC state after a temperature upshift (25°C); V. parahaemolyticus ATCC 33844 and V. parahaemolyticus ATCC 27969 were successfully reactivated from a VBNC state in ASW microcosms containing <5% NaCl, following enrichment in ASW medium (pH 7). SIGNIFICANCE AND IMPACT OF THE STUDY: Few studies have evaluated the characteristics of and detection methods for viable but nonculturable (VBNC) Vibrio parahaemolyticus induced by cold-starvation. Currently, VBNC cells are routinely detected by SYTO9 and propidium iodide double staining. However, viable cell counts might be overestimated by this approach, suggesting that the fluorescence dyes may be ineffective for accurately determining the viability of bacterial cells. We demonstrated that quantitative real-time polymerase chain reaction with propidium monoazide, which selectively permeates damaged cell membranes, can be used to obtain viable cell counts of V. parahaemolyticus after its evolution to a VBNC state under cold-starvation conditions.


Asunto(s)
Azidas/química , Microscopía Fluorescente/métodos , Propidio/análogos & derivados , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Vibrio parahaemolyticus/aislamiento & purificación , Frío , Viabilidad Microbiana/efectos de los fármacos , Propidio/química , Vibrio parahaemolyticus/genética
2.
Lett Appl Microbiol ; 66(4): 300-305, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29315769

RESUMEN

Klebsiella oxytoca naturally produces a large amount of 2,3-butanediol (2,3-BD), a promising chemical with wide industrial applications, along with various by-products. Previously, we have developed a metabolically engineered K. oxytoca ΔldhA ΔpflB strain to reduce the formation of by-products. To improve 2,3-BD productivity and examine the stability of K. oxytoca ΔldhA ΔpflB strain for industrial application, a semi-continuous two-stage simultaneous saccharification and fermentation (STSSF) process was developed. The STSSF with the K. oxytoca ΔldhA ΔpflB mutant using cassava as a carbon source could produce 108 ± 3·73 g(2,3-BD)  l-1 with a yield of 0·45 g(2,3-BD)  g(glucose)-1 and a productivity of 3·00 g(2,3-BD) l-1  h-1 . No apparent changes in the final titre, yield and productivity of 2,3-BD were observed for up to 20 cycles of STSSF. Also, microbial contamination and spontaneous mutation of the host strain with potential detrimental effects on fermentation efficiency did not occur during the whole fermentation period. These results strongly underpin that the K. oxytoca ΔldhA ΔpflB mutant is stable and that the STSSF process is commercially exploitable. SIGNIFICANCE AND IMPACT OF THE STUDY: There is growing interest in the production of 2,3-butanediol (2,3-BD) from renewable resources by microbial fermentation because of its wide applications to specialty and commodity chemical industries. Klebsiella oxytoca usually produces 2,3-BD as a major end product during the fermentation of carbohydrates. This is the first study to provide a high-efficiency simultaneous saccharification and 2,3-BD fermentation process. Also, this study proves the stability of a metabolically engineered 2,3-BD overproducing K. oxytoca strain for industrial application.


Asunto(s)
Reactores Biológicos/microbiología , Butileno Glicoles/metabolismo , Klebsiella oxytoca/metabolismo , Ingeniería Metabólica/métodos , Fermentación/genética , Fermentación/fisiología , Glucosa/metabolismo
3.
Neuroscience ; 157(2): 297-308, 2008 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-18848605

RESUMEN

The variability in the behavioral outcome of human and nonhuman animals after stroke raises the question whether the way that a stroke occurs is a contributing factor. Photothrombotic stroke in rats has been reported to produce especially variable results, with some animals showing either slight to no impairment to other animals displaying severe impairments. The present study investigated this variability. Rats received three different-sized photothrombotic treatments and were contrasted to rats receiving a "standard" motor cortex stroke produced by pial stripping. Rats were assessed acutely and chronically on a skilled reaching for food task using end-point measures and movement assessment in a constraint-induced rehabilitation paradigm. The results indicated that as the size of the photothrombotic infarct approached the size of the pial strip infarct so did chronic behavioral deficits. Nevertheless there were differences in the time course of recovery. Rats with photothrombotic lesions of all sizes were less impaired in the acute period of recovery both on measures of learned nonuse and constrained-induced recovery. The findings are discussed in relation to the idea that whereas the course of recovery might be altered as a function of the type of stroke, chronic deficits are more closely related to the ensuing damage.


Asunto(s)
Conducta Alimentaria/fisiología , Corteza Motora/fisiopatología , Accidente Cerebrovascular/etiología , Accidente Cerebrovascular/patología , Técnicas de Ablación/métodos , Análisis de Varianza , Animales , Conducta Animal , Condicionamiento Operante/fisiología , Modelos Animales de Enfermedad , Femenino , Trombosis Intracraneal/complicaciones , Actividad Motora/fisiología , Ratas , Ratas Long-Evans , Factores de Tiempo
4.
Methods Find Exp Clin Pharmacol ; 30(6): 443-50, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18850045

RESUMEN

In this study, we investigated the effect of Daio-Orengedoku-to (DOT) on ischemic brain damage in a rat model of focal ischemia-reperfusion and attempted to identify synergistic effects for the combination of edaravone and DOT against ischemic insult. Ischemia was induced by intraluminal occlusion of the right middle cerebral artery for 2 h and reperfusion followed for 22 h. To determine the neuroprotective effect of DOT, it was administered orally just before reperfusion and then 2 h after reperfusion. To examine the effects of combination therapy on survival, rats were divided into groups treated with edaravone, DOT, and edaravone and DOT. Microglial activation, neutrophil infiltration and brain-derived neurotrophic factor (BDNF) expression were examined in surviving animals. Infarct volume was significantly reduced by DOT (100, 200 and 400 mg/kg; P < 0.05), and edaravone plus DOT markedly improved the survival rate after transient ischemia (P = 0.0133). Microglial activation was reduced by edaravone and DOT and their combination (P < 0.05), and neutrophil infiltration was lowered in these groups (P < 0.05). BDNF-positive cells were increased in the combination edaravone and DOT group (P < 0.05). It appears that the neuroprotective mechanisms of combined therapy involve inhibition of microglial activation, reduction of invading neutrophils and enhancement of BDNF expression.


Asunto(s)
Antipirina/análogos & derivados , Medicamentos Herbarios Chinos/uso terapéutico , Depuradores de Radicales Libres/uso terapéutico , Ataque Isquémico Transitorio/tratamiento farmacológico , Fármacos Neuroprotectores , Animales , Antipirina/uso terapéutico , Factor Neurotrófico Derivado del Encéfalo/genética , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Quimioterapia Combinada , Edaravona , Inmunohistoquímica , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Infarto de la Arteria Cerebral Media/patología , Masculino , Microglía/efectos de los fármacos , Infiltración Neutrófila/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/psicología
5.
Cell Death Differ ; 13(10): 1763-75, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16485034

RESUMEN

We investigated the cytoprotective mechanisms of flunarizine in cisplatin-induced death of auditory cells. Concomitant with an increase in viability, treatment with flunarizine resulted in a marked dissociation of Nrf2/Keap1 and subsequent intranuclear translocation of Nrf2, which was mediated by PI3K-Akt signaling. Overexpression of Nrf2 protected cells from cisplatin along with transcriptional activation of ARE to generate heme oxygenase-1 (HO-1). Pretreatment with flunarizine predominantly increased the transcriptional activity of HO-1 among Nrf2-driven transcripts, including HO-1, NQO1, GCLC, GCLM, GST micro-1, and GSTA4. Furthermore, both pharmacological inhibition and siRNA transfection of HO-1 completely abolished the flunarizine-mediated protection of HEI-OC1 cells and the primary rat (P2) organ of Corti explants from cisplatin. These results suggest that Nrf2-driven transcriptional activation of ARE through PI3K-Akt signaling augments the generation of HO-1, which may be a critically important determinant in cellular response toward cisplatin and the cytoprotective effect of flunarizine against cisplatin.


Asunto(s)
Cisplatino/toxicidad , Flunarizina/farmacología , Hemo-Oxigenasa 1/genética , Factor 2 Relacionado con NF-E2/metabolismo , Órgano Espiral/efectos de los fármacos , Órgano Espiral/metabolismo , Transporte Activo de Núcleo Celular/efectos de los fármacos , Animales , Antioxidantes/metabolismo , Apoptosis/efectos de los fármacos , Secuencia de Bases , Línea Celular , ADN Complementario/genética , Hemo-Oxigenasa 1/antagonistas & inhibidores , Técnicas In Vitro , Ratones , Factor 2 Relacionado con NF-E2/genética , Órgano Espiral/citología , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , ARN Interferente Pequeño/genética , Ratas , Ratas Sprague-Dawley , Transducción de Señal/efectos de los fármacos , Activación Transcripcional/efectos de los fármacos
6.
J Med Genet ; 40(4): 242-8, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12676893

RESUMEN

Recessive mutations of SLC26A4 (PDS) are a common cause of Pendred syndrome and non-syndromic deafness in western populations. Although south and east Asia contain nearly one half of the global population, the origins and frequencies of SLC26A4 mutations in these regions are unknown. We PCR amplified and sequenced seven exons of SLC26A4 to detect selected mutations in 274 deaf probands from Korea, China, and Mongolia. A total of nine different mutations of SLC26A4 were detected among 15 (5.5%) of the 274 probands. Five mutations were novel and the other four had seldom, if ever, been identified outside east Asia. To identify mutations in south Asians, 212 Pakistani and 106 Indian families with three or more affected offspring of consanguineous matings were analysed for cosegregation of recessive deafness with short tandem repeat markers linked to SLC26A4. All 21 SLC26A4 exons were PCR amplified and sequenced in families segregating SLC26A4 linked deafness. Eleven mutant alleles of SLC26A4 were identified among 17 (5.4%) of the 318 families, and all 11 alleles were novel. SLC26A4 linked haplotypes on chromosomes with recurrent mutations were consistent with founder effects. Our observation of a diverse allelic series unique to each ethnic group indicates that mutational events at SLC26A4 are common and account for approximately 5% of recessive deafness in south Asians and other populations.


Asunto(s)
Proteínas Portadoras/genética , Sordera/genética , Proteínas de Transporte de Membrana , Asia Sudoriental/epidemiología , Cromosomas Humanos Par 7/genética , ADN/química , ADN/genética , Análisis Mutacional de ADN , Sordera/epidemiología , Sordera/patología , Salud de la Familia , Femenino , Frecuencia de los Genes , Genes Recesivos/genética , Haplotipos , Humanos , Corea (Geográfico)/epidemiología , Masculino , Mutación , Mutación Missense , Linaje , Mapeo Físico de Cromosoma , Transportadores de Sulfato
7.
Cardiovasc Res ; 49(4): 872-81, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11230987

RESUMEN

OBJECTIVES: A healthy, intact coronary artery endothelium is important because most common coronary artery diseases result from loss of endothelial integrity. In this study, we explored the biological significance of the angiopoietin-Tie2 system in porcine coronary artery. METHODS: Cultured porcine coronary artery endothelial cells and explanted coronary arteries were used. RESULTS: Immunohistochemical analyses indicated that Ang1 is selectively expressed in vascular muscular cells, whereas angiopoietin-2 (Ang2) and Tie2 are selectively expressed in endothelial cells. Accordingly, Ang1 mRNA is mainly expressed in cultured porcine coronary artery vascular smooth muscle cells, whereas Ang2 and Tie2 mRNAs are mainly expressed in cultured porcine coronary artery endothelial cells (PCAECs). Ang1 (200 ng/ml) induced Tie2 phosphorylation, while Ang2 (200 ng/ml) did not produce Tie2 phosphorylation. Ang1 increased the survival of cultured PCAECs during apoptosis induced by oxidized low-density lipoprotein (OxLDL). This survival effect was does-dependent and PI. Furthermore, Ang1 also protected endothelial cells of explanted coronary artery against OxLDL-induced apoptosis artery. CONCLUSION: These results suggest that adult coronary artery contains Ang1-Tie2 components that enhance endothelial cell survival to help maintain the normal integrity of the coronary artery endothelium.


Asunto(s)
Endotelio Vascular/metabolismo , Inhibidores Enzimáticos/farmacología , Glicoproteínas de Membrana/farmacología , Músculo Liso Vascular/metabolismo , Proteínas/farmacología , Proteínas Proto-Oncogénicas , Proteínas Tirosina Quinasas Receptoras/antagonistas & inhibidores , Proteínas Tirosina Quinasas Receptoras/metabolismo , Análisis de Varianza , Angiopoyetina 1 , Angiopoyetina 2 , Animales , Apoptosis , Células Cultivadas , LDL-Colesterol/farmacología , Vasos Coronarios , Endotelio Vascular/citología , Inmunohistoquímica , Glicoproteínas de Membrana/genética , Microscopía de Contraste de Fase , Músculo Liso Vascular/citología , Proteínas de Neoplasias/metabolismo , Fosforilación , Proteínas/genética , ARN Mensajero/análisis , Proteínas Tirosina Quinasas Receptoras/genética , Receptor TIE-2 , Porcinos
8.
Ann Otol Rhinol Laryngol ; 101(8): 659-64, 1992 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1497271

RESUMEN

Many variables affect the audiologic performance of cochlear implantees. With current methods of evaluation, it is difficult to directly compare auditory function with different speech coding strategies. We compared the audiologic performance directly with F0F1F2 and multipeak speech coding strategies in the same implanted ear of eight Korean cochlear implantees. We tested word and phoneme recognition abilities using Korean word lists for speech audiometry and two-syllable nonsense words, respectively. With the multipeak coding strategy, a significant difference in discrimination ability was found in the initial fricative consonant phonemes (/s/,/ss/,/h/). Our results suggest that the improvement of speech recognition ability with the multipeak coding strategy comes primarily from the better understanding of the initial fricative consonants.


Asunto(s)
Audiometría del Habla , Implantes Cocleares , Sordera/rehabilitación , Adulto , Anciano , Humanos , Corea (Geográfico) , Persona de Mediana Edad , Fonética , Percepción del Habla/fisiología
9.
Acta Otolaryngol ; 120(8): 933-9, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11200587

RESUMEN

For the advanced study of the cell and molecular biology of middle ear mucosa, an in vitro cell culture system is required. Although middle ear epithelial cells have been cultured from various species of laboratory animal, there have been no reports concerning a serial subculture system of human middle ear epithelial cells. In this paper, we describe the establishment of a primary culture system of human middle ear epithelial cells using a serum-free conditioned medium and the characterization of these cells by the expression of phenotypic characteristics of epithelial cells and mucin genes. Cultured cells were anchorage-dependent in terms of growth and showed a polygonal cobblestone-like appearance: desmosomes in the cell junction were observed by electron microscopy. In the immunocytochemical study, cytokeratin (epithelial cell marker) was expressed in all cultured cells. but von Willebrand factor (endothelial cell marker) was not. Unexpectedly, vimentin (fibroblast marker) was locally expressed, and a double stain showed the co-expression of both cytokeratin and vimentin in the same cell. The products of reverse transcriptase polymerase chain reaction from cultured cells yielded distinct bands compatible with the expected sizes of the MUC1, MUC2, MUC5AC and MUC5B genes. This culture system will allow us to prepare the cell line and to perform advanced studies of human middle ear mucosal biology.


Asunto(s)
Oído Medio/citología , Células Epiteliales , Expresión Génica , Mucinas/genética , Células Cultivadas , Medios de Cultivo , Humanos , Inmunohistoquímica , Fenotipo
10.
Acta Otolaryngol ; 120(8): 944-9, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11200589

RESUMEN

Mucous hypersecretion is a major complication of otitis media and can prolong the disease course and increase morbidity. Mucin, a major component of mucus, is a macromolecular complex of glycoprotein and makes mucus viscous. Lysozyme is a secretory element of the middle ear mucosa. which has a non-specific and innate antibacterial function. We attempted to identify factors that regulate these secretory products and their morphological phenotype using cultured human middle ear epithelial cells. Cellular differentiation was induced by creating an air liquid interface on culture day 9 in serum-free conditioned media. Omission of retinoic acid (RA) caused decrease in the secretion of mucin and lysozyme, and in the cellular expression of MUC 2, MUC 5AC and MUC 5B mRNA. In contrast, removal of triiodothyronine (T3) caused an increase in the secretion of mucin and the level of MUC5AC mRNA. When hydrocortisone (HC) was removed from the media, the secretion of mucin was decreased with out an apparent change of message level. The expression of MUC 1 mRNA was not changed by the respective deficiency of RA. T3 or HC. The effect of T3 or HC on lysozyme was not significant. This study shows that RA, T3 and HC influence the morphological phenotype and the secretory function of mucin and lysozyme in cultured human middle ear epithelial cells. This culture system can serve as an in vitro model for study of the regulation of various cellular secretions in human middle ear epithelium.


Asunto(s)
Antiinflamatorios/farmacología , Antineoplásicos/farmacología , Oído Medio/citología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Hidrocortisona/farmacología , Mucinas/biosíntesis , Mucinas/efectos de los fármacos , Muramidasa/biosíntesis , Muramidasa/efectos de los fármacos , Tretinoina/farmacología , Triyodotironina/farmacología , Células Cultivadas , Oído Medio/efectos de los fármacos , Oído Medio/metabolismo , Humanos
11.
Am J Chin Med ; 29(3-4): 445-58, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11789587

RESUMEN

Uwhangchungsimwon (pill, UC) is one of the traditional Korean medical prescriptions that has been most frequently used for stroke. To characterize the effects of UC on human neuronal cells, the human neuroblastoma cell line IMR32 was treated with UC, and cell viability, cell proliferation, apoptosis, and gene expression were analyzed. The effect of UC on recovery of cell viability was analyzed following stress induction by nutrient depletion or cold shock. Flow cytometric analysis of the cell cycle showed that UC inhibits cell cycle progression of IMR32 in a dose- and time-dependent manner. UC was also identified to increase cell viability and suppress apoptosis induction by a DNA-damaging agent, etoposide. Quantitative RT-PCR analysis revealed that expressions of the p53 tumor suppressor gene and its downstream effect, Waf1, are stimulated whereas expressions of positive cell cycle regulators, c-Myc, c-Fos, and Cyclin D1 were repressed by UC treatment. Moreover, while expression levels of apoptosis inhibitors, Bcl-2 and Bcl-XL were increased following UC treatment, that of an apoptosis promoter, Bax, was decreased. In addition, expression of BMP-7, which has been recently demonstrated to improve the motor neuron recovery from stroke, was induced by UC while it was not detected in untreated cells. Taken together, our data suggest that the pharmacoclinical effects of UC might be derived in part from its negative regulation of cell proliferation and apoptosis through the transcriptional control of related genes.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Expresión Génica/efectos de los fármacos , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Plantas Medicinales , Factor de Crecimiento Transformador beta , Apoptosis/efectos de los fármacos , Proteína Morfogenética Ósea 7 , Proteínas Morfogenéticas Óseas/genética , Ciclo Celular , División Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Ciclina D1/genética , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Ciclinas/genética , Genes fos , Genes myc , Histonas/genética , Humanos , Neuroblastoma , Neuronas/citología , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-bcl-2/genética , Accidente Cerebrovascular , Transcripción Genética , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/genética , Proteína X Asociada a bcl-2 , Proteína bcl-X
12.
Am J Chin Med ; 28(1): 57-67, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10794117

RESUMEN

The effects of gamigeonsim-tang (GGT) on cellular proliferation and expression of cell cycle-related genes were investigated in human smooth muscle cell HISM. HISM cells were treated with an aqueous extract of GGT. Cellular proliferation was investigated by an immunocytometric analysis of PCNA expression and a flow cytometric analysis of the cell cycle progression. Reduced expression of PCNA and a significant accumulation of G1 phase cells were observed following treatment, indicating that GGT inhibits cellular proliferation of human smooth muscle cells. To explore whether GGT affects the transcription of cell cycle-regulating genes, we evaluated mRNA expression of p53, p21Waf1 PCNA, Cyclin D1, Cdc2, Histone H3, c-Myc, and c-Fos using a quantitative RT-PCR analysis. While increased expressions of two negative cell cycle regulators, p53 and p21Waf1 were found, reduced expressions of cell cycle stimulators, PCNA, c-Fos, and c-Myc, were identified following treatment. Taken together, our study demonstrates that GGT inhibits cellular proliferation of human smooth muscle cell through the up- and down-regulation of growth-inhibiting and growth-promoting genes, respectively.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Genes cdc , Músculo Liso/efectos de los fármacos , Proteína Quinasa CDC2/genética , División Celular/efectos de los fármacos , Ciclina D1/genética , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Ciclinas/genética , Regulación hacia Abajo/efectos de los fármacos , Histonas/genética , Humanos , Corea (Geográfico) , Músculo Liso/citología , Antígeno Nuclear de Célula en Proliferación/genética , Proteínas Proto-Oncogénicas c-fos/genética , Proteínas Proto-Oncogénicas c-myc/genética , Transcripción Genética/efectos de los fármacos , Proteína p53 Supresora de Tumor/genética , Regulación hacia Arriba/efectos de los fármacos
13.
Br J Radiol ; 85(1018): e891-8, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22972978

RESUMEN

OBJECTIVE: To investigate the potential diagnostic value of dual-energy CT (DECT) with virtual non-enhanced (VNE) and iodine-only images, and to determine the optimal mixed ratio of blended images for evaluation of pancreatic diseases. METHODS: Multiphasic DECT was performed in 44 patients with focal pancreatic disease. DECT was used during the pancreatic and hepatic venous phases, and a peak kilovoltage of 120 kVp was used for both non-contrast phases. For qualitative analysis of the CT images, two radiologists assessed three image sets (VNE, iodine-only and blended images) in order to determine the acceptability of VNE in replacing true non-enhanced (TNE) images, the added value of iodine-only images and the preferred blending ratio. For quantitative analyses, the CT numbers and image noise of the pancreatic parenchyma, lesions, aorta and psoas muscle were measured. The contrast-to-noise ratio of the lesion was calculated on the pancreatic phase images. The effective radiation dose for DECT and TNE images was calculated. Statistical comparisons were made using the Friedman test, the Wilcoxon test, the paired t-test and repeated measures of analysis of variation with Bonferroni correction for multiple comparisons. RESULTS: The level of acceptance of the VNE images in replacing TNE images was 90.9%. Regarding the iodine-only images, 50% of the cases were found to have an added value. The linear-blended images with a weighting factor of 0.5 were preferred. CONCLUSIONS: DECT was able to provide high-quality VNE images that could replace TNE images and iodine-only images showing an added value. Blended images with a weighting factor of 0.5 were preferred by the reviewers.


Asunto(s)
Tomografía Computarizada Multidetector/métodos , Neoplasias Pancreáticas/diagnóstico por imagen , Adulto , Anciano , Medios de Contraste , Femenino , Humanos , Yohexol/análogos & derivados , Masculino , Persona de Mediana Edad , Variaciones Dependientes del Observador , Dosis de Radiación , Estudios Retrospectivos
14.
Prostate Cancer Prostatic Dis ; 15(4): 369-73, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22890388

RESUMEN

BACKGROUND: Runt-related transcription factor 2 (RUNX2) is a transcription factor that is closely related to bone formation, and prostate cancer (CaP) is the most common cancer to metastasize to bone. The present study investigated the expression levels of RUNX2 in human prostate tissue, and the correlation between RUNX2 levels and the clinicopathological characteristics of CaP. METHODS: A case-control study was conducted including 114 cases of newly diagnosed CaP and 114 age-matched BPH patients as controls. RUNX2 expression was estimated using real-time PCR and immunohistochemical staining. RESULTS: The mRNA expression of RUNX2 did not differ between CaP tissues and non-cancer BPH controls (P=0.825). However, RUNX2 expression was significantly decreased in patients with elevated PSA levels (≥20 ng ml(-1)), a Gleason score ≥8 and metastatic disease compared to those with low PSA, low Gleason score and non-metastatic disease (P=0.023, 0.005 and 0.014, respectively). Immunohistochemical analysis showed that 65.2% of the patients with positive RUNX2 nuclear staining had metastatic disease, which was present in only 25.9% of those with negative staining (P=0.010). CONCLUSIONS: RUNX2 mRNA expression was negatively correlated with CaP aggressiveness. Moreover, the nuclear location of RUNX2 may be a prognostic marker of metastasis in CaP.


Asunto(s)
Neoplasias Óseas , Subunidad alfa 1 del Factor de Unión al Sitio Principal , Neoplasias de la Próstata , Transcripción Genética , Anciano , Anciano de 80 o más Años , Neoplasias Óseas/genética , Neoplasias Óseas/patología , Neoplasias Óseas/secundario , Nucléolo Celular/metabolismo , Nucléolo Celular/ultraestructura , Subunidad alfa 1 del Factor de Unión al Sitio Principal/genética , Subunidad alfa 1 del Factor de Unión al Sitio Principal/metabolismo , Regulación Neoplásica de la Expresión Génica , Humanos , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Estadificación de Neoplasias , Pronóstico , Neoplasias de la Próstata/genética , Neoplasias de la Próstata/metabolismo , Neoplasias de la Próstata/patología
15.
Clin Genet ; 67(2): 160-5, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15679828

RESUMEN

Sensorineural hearing loss associated with enlargement of the vestibular aqueduct (EVA) can be associated with mutations of the SLC26A4 gene. In western populations, less than one-half of the affected individuals with EVA have two mutant SLC26A4 alleles, and EVA is frequently caused by unknown genetic or environmental factors alone or in combination with a single SLC26A4 mutation as part of a complex trait. In this study, we ascertained 26 Korean probands with EVA and performed nucleotide sequence analysis to detect SLC26A4 mutations. All subjects had bilateral EVA, and 20 of 26 were sporadic (simplex) cases. Fourteen different mutations were identified, including nine novel mutations. Five mutations were recurrent and accounted for 80% of all mutant alleles, providing a basis for the design and interpretation of cost-efficient mutation detection algorithms. Two mutant alleles were identified in 21 (81%), one mutant allele was detected in three (11%), and zero mutant allele was detected in two (8%) of 26 probands. The high proportion of Korean probands with two SLC26A4 mutations may reflect a reduced frequency of other genetic or environmental factors causing EVA in comparison to western populations.


Asunto(s)
Pérdida Auditiva/etnología , Pérdida Auditiva/genética , Proteínas de Transporte de Membrana/genética , Polimorfismo Genético , Acueducto Vestibular/patología , Adolescente , Adulto , Transporte Biológico , Estudios de Casos y Controles , Niño , Preescolar , Análisis Mutacional de ADN , Femenino , Humanos , Corea (Geográfico) , Masculino , Transportadores de Sulfato , Sulfatos
16.
Biotechnol Bioeng ; 67(2): 157-64, 2000 Jan 20.
Artículo en Inglés | MEDLINE | ID: mdl-10592513

RESUMEN

Oxygen supply is one of the major problems in the production of useful proteins by cultured animal cells and therefore it is of importance to devise a system by which a high productivity of human therapeutic recombinant proteins can be maintained or enhanced under low oxygen concentrations. A number of hypoxia-inducible genes have been found in animal cells and the induction in most cases is due to hypoxic activation of the gene transcription. A consensus sequence (HRE = hypoxia-response enhancer) responsible for the hypoxic activation exists in these genes and the binding of a protein, which is widely distributed in animal cells, to this sequence responding to hypoxia activates the promoter activity. The promoter of lactate dehydrogenase A gene is active in Chinese hamster ovary (CHO) cells and the vicinal HRE stimulates the promoter activity efficiently in hypoxia. We have prepared a number of permanent CHO cell lines producing recombinant human erythropoietin (Epo) under control of this promoter/HRE. Epo production was highly hypoxia-inducible when the wild-type of HRE was used but uninducible when the mutant HRE was used. There was little difference in the in vitro and in vivo activities, and glycosylation between Epo produced by the cells cultured in 21% and 2% oxygen. Furthermore, forced expression of hypoxia-inducible factor-1alpha (HIF-1alpha) enhanced Epo production in all oxygen concentrations. These results indicate that a biological strategy based on the hypoxic induction of gene transcription provides a novel system which guarantees a high productivity even uner low oxygen concentrations.


Asunto(s)
Hipoxia de la Célula/genética , Elementos de Facilitación Genéticos , Ingeniería de Proteínas/métodos , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Animales , Secuencia de Bases , Células CHO/efectos de los fármacos , Células CHO/metabolismo , Carbohidratos/análisis , Cobalto/farmacología , Cricetinae , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Eritropoyetina/análisis , Eritropoyetina/genética , Eritropoyetina/aislamiento & purificación , Eritropoyetina/metabolismo , Humanos , Factor 1 Inducible por Hipoxia , Subunidad alfa del Factor 1 Inducible por Hipoxia , Datos de Secuencia Molecular , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Oxígeno/metabolismo , Regiones Promotoras Genéticas , Proteínas Recombinantes/aislamiento & purificación , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Transcripción Genética , Activación Transcripcional
17.
Korean J Intern Med ; 14(2): 78-81, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10461429

RESUMEN

Sweet's syndrome (SS) has been reported as an association with malignant neoplasms and autoimmune diseases, e.g., Behçet's disease, Sjogren's syndrome, and rheumatoid arthritis. But dermatomyositis (DM), one of the rare autoimmune diseases, was not reported as an associated disease of SS. We describe an interesting case of SS associated with DM. Diagnosis was made by skin biopsy, and subsequent clinical resolution occurred after institution of prednisolone.


Asunto(s)
Dermatomiositis/complicaciones , Síndrome de Sweet/complicaciones , Dermatomiositis/tratamiento farmacológico , Dermatomiositis/patología , Humanos , Masculino , Persona de Mediana Edad , Prednisolona/uso terapéutico , Síndrome de Sweet/tratamiento farmacológico , Síndrome de Sweet/patología
18.
Biosci Biotechnol Biochem ; 61(4): 670-4, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9145527

RESUMEN

Bacillus brevis secretes a large amount of cell wall proteins into the culture medium. For construction of Bacillus brevis expression-secretion vectors of human erythropoietin (EPO) and the extracellular domain of mouse erythropoietin receptor (sEPOR), cDNA for each mature form was inserted into a plasmid containing the promoter region and the signal-peptide encoding region of a cell wall protein. Culture supernatants of transformants were affinity purified using a monoclonal antibody-fixed gel for EPO and and EPO-fixed gel for sEPOR. The affinity purification efficiently removed unwanted proteins, giving samples with sufficiently high purity to analyze amino acid sequences of N-terminal regions and biological activities. Combination of this secretory production and affinity purification may facilitate isolation of a large amount of pure EPO and sEPOR, and is useful for further understanding the molecular mechanism of interaction between EPO and EPOR.


Asunto(s)
Bacillus/genética , Eritropoyetina/genética , Receptores de Eritropoyetina/genética , Secuencia de Aminoácidos , Animales , Línea Celular , Clonación Molecular , Cricetinae , Eritropoyetina/aislamiento & purificación , Eritropoyetina/metabolismo , Humanos , Ratones , Datos de Secuencia Molecular , Unión Proteica , Receptores de Eritropoyetina/aislamiento & purificación , Receptores de Eritropoyetina/metabolismo
19.
Cytotechnology ; 25(1-3): 79-88, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22358882

RESUMEN

Oxygen is a limiting nutrient in animal cell culture and its supply is still worthy of improvement for production of useful proteins with a high efficiency. From a different point of view, development of the system by which a high productivity can be maintained even under hypoxic condition as well as under normoxic condition may be important. A number of hypoxia-inducible genes have been found in eucaryotic cells and the induction in most cases, if not all, is due to hypoxic activation of the gene transcription. Transcription of erythropoietin gene is highly hypoxia-inducible and the induction is achieved by binding of a protein, which is widely distributed in animal cells, to a short DNA stretch (erythropoietin enhancer) in the 3' flanking region of erythropoietin gene. Using a hepatoma cell line (Hep3B) that produces the endogenous erythropoietin in an oxygen-dependent manner and Chinese hamster ovary cells that have been widely used for production of recombinant proteins, we show that, under hypoxic condition, the erythropoietin enhancer can activate not only the promoter of erythropoietin gene but also promoters of cytomegalovirus early genes and eucaryotic polypeptide chain elongation factor gene, both of which are very active in animal cells under normoxic condition.

20.
Vaccine ; 19 Suppl 1: S17-25, 2000 Dec 08.
Artículo en Inglés | MEDLINE | ID: mdl-11163458

RESUMEN

The sterility of the eustachian tube and tympanic cavity of normal individuals is maintained not only by the adaptive immune system, but also by the mucociliary system and the antimicrobial molecules of innate immunity. Mucin production and periciliary fluid homeostasis are essential for normal mucociliary function and dysfunction of this system is an important risk factor for otitis media. The secreted antimicrobial molecules of the tubotympanum include lysozyme, lactoferrin, beta defensins, and the surfactant proteins A and D (SP-A, SP-D). Defects in the expression or regulation of these molecules may also be the major risk factor for otitis media.


Asunto(s)
Trompa Auditiva/citología , Otitis Media/etiología , Membrana Timpánica/citología , Animales , Acuaporinas/genética , Acuaporinas/fisiología , Niño , Preescolar , Cilios/fisiología , Susceptibilidad a Enfermedades , Células Epiteliales/fisiología , Trompa Auditiva/inmunología , Trompa Auditiva/microbiología , Perfilación de la Expresión Génica , Glicoproteínas/fisiología , Homeostasis , Humanos , Inmunidad Innata , Lactante , Lactoferrina/fisiología , Ratones , Mucinas/genética , Mucinas/fisiología , Moco/fisiología , Muramidasa/fisiología , Proteolípidos/fisiología , Proteína A Asociada a Surfactante Pulmonar , Proteína D Asociada a Surfactante Pulmonar , Proteínas Asociadas a Surfactante Pulmonar , Surfactantes Pulmonares/fisiología , Conejos , Ratas , Membrana Timpánica/inmunología , Membrana Timpánica/microbiología , beta-Defensinas/fisiología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda